chr20-38131210-T-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_004613.4(TGM2):​c.1796A>T​(p.Gln599Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000356 in 1,461,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

TGM2
NM_004613.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.54

Publications

0 publications found
Variant links:
Genes affected
TGM2 (HGNC:11778): (transglutaminase 2) Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. Finally, the encoded protein is the autoantigen implicated in celiac disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TGM2 Gene-Disease associations (from GenCC):
  • type 2 diabetes mellitus
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17297062).
BS2
High AC in GnomAdExome4 at 52 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGM2NM_004613.4 linkc.1796A>T p.Gln599Leu missense_variant Exon 12 of 13 ENST00000361475.7 NP_004604.2 P21980-1V9HWG3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGM2ENST00000361475.7 linkc.1796A>T p.Gln599Leu missense_variant Exon 12 of 13 1 NM_004613.4 ENSP00000355330.2 P21980-1
TGM2ENST00000469269.1 linkn.1441A>T non_coding_transcript_exon_variant Exon 2 of 3 2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000757
AC:
19
AN:
250948
AF XY:
0.0000959
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000356
AC:
52
AN:
1461718
Hom.:
0
Cov.:
31
AF XY:
0.0000481
AC XY:
35
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000568
AC:
49
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53254
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1112008
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.000115
AC:
14

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 11, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1796A>T (p.Q599L) alteration is located in exon 12 (coding exon 12) of the TGM2 gene. This alteration results from a A to T substitution at nucleotide position 1796, causing the glutamine (Q) at amino acid position 599 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.069
T
Eigen
Benign
0.037
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.17
T
MetaSVM
Benign
-0.74
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
4.5
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.030
N
REVEL
Benign
0.17
Sift
Benign
0.25
T
Sift4G
Benign
0.41
T
Polyphen
0.057
B
Vest4
0.54
MutPred
0.58
Loss of disorder (P = 0.0402);
MVP
0.64
MPC
0.22
ClinPred
0.056
T
GERP RS
5.1
Varity_R
0.41
gMVP
0.67
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747144340; hg19: chr20-36759612; API